trial · primary record
pathogen-specific CTLs
Pathogen Infection
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2026-07-31 |
| Primary endpoint | Using CTCAE 4 standard to evaluate the level of adverse events after receiving autologous or allogenic pathogen-specific CTL infusion |
| Registry ID | NCT03159364 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:33.826Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03159364
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.